The appointment of Mercier, who arrives following her role as the company’s European Commercial and Access Lead, will see her lead a critical market for Bristol-Myers Squibb as the company continues its evolution towards becoming a Speciality Biopharma leader. She replaces outgoing General Manager Amadou Diarra who moves on to a new role within the Bristol-Myers Squibb Global Policy and Government Affairs team.
